Hotaling Investment Management’s GSK GSK Stock Holding History

Hotaling Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$492K	Hold	13,998	–	–	0.22%	81
2022 Q3	$412K	Sell	13,998 -6,320	-31%	-$240K	0.2%	84
2022 Q2	$1.11M	Buy	20,318 +11,176	+122%	+$617K	0.48%	66
2022 Q1	$498K	Sell	9,142 -6,290	-41%	-$342K	0.19%	90
2021 Q4	$851K	Buy	15,432 +7,090	+85%	+$369K	0.3%	77
2021 Q3	$398K	Sell	8,342 -6,290	-43%	-$316K	0.17%	88
2021 Q2	$728K	Buy	14,632 +6,290	+75%	+$302K	0.3%	78
2021 Q1	$372K	Hold	8,342	–	–	0.17%	90
2020 Q4	$384K	Sell	8,342 -160	-2%	-$7.35K	0.18%	85
2020 Q3	$400K	Buy	+8,502	New	+$426K	0.22%	78

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Hotaling Investment Management's GSK Position: Q4 2022 in Review

Hotaling Investment Management held its GSK (GSK) position steady in Q4 2022 at 13,998 shares worth $492K. The position accounts for 0.22% of the portfolio, ranked #81.

Hotaling Investment Management first reported a position in GSK in Q3 2020 and has held it in 10 quarters since. The position peaked at $1.11M in Q2 2022. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

Hotaling Investment Management held 13,998 shares of GSK worth $492K as of Q4 2022.
Hotaling Investment Management left its GSK share count unchanged in Q4 2022.
GSK made up 0.22% of Hotaling Investment Management's portfolio in Q4 2022, its #81 holding.
Hotaling Investment Management first reported a position in GSK in Q3 2020 and has held it in 10 quarters since.
Hotaling Investment Management's GSK position peaked at $1.11M in Q2 2022.
813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Hotaling Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.